COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis?

Journal article

The “lickety-split” development of COVID-19 vaccines 326 days from when the SARS-COV-2 virus was first sequenced is indeed one of the public health successes of the 21st century. Particularly because an 18-month target was initially considered reasonable, and having achieved this success, a “moonshot” goal to ensure that a vaccine is available within 100 days after the next pandemic pathogen is recognized has been set [1]

Authors: Akande, OW; Igumbor, EU; Elimian, KO; Ohonsi, CE; Nwozor, L

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: International Society of Global Health
• Journal: Journal of Global Health
• Volume: 12
• Pages: 03055-03055
• Article number: 03055
• Publication date: 2022-08-02
• DOI: 10.7189/jogh.12.03055
• EISSN: 2047-2986
• ISSN: 2047-2978
• Language: English
• Keywords: Internal medicine; Disease; Infectious disease (medical specialty); Pandemic; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Status quo; Outbreak; 2019-20 coronavirus outbreak; Political science; Coronavirus Infections; Biology; MEDLINE; Medicine; Virology